We only have this paper's title and publication details.
Read it at the sourceEvaluates AI assessment during topical ruxolitinib treatment for vitiligo, suggesting an innovative approach to therapy monitoring.
No takes yet. Share an insight, caveat, or question.
Paganelli et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: